These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 707498)

  • 21. [Should dosing practice in aminoglycosides therapy be changed?].
    Bruun JN; Brubakk O
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3115. PubMed ID: 10522473
    [No Abstract]   [Full Text] [Related]  

  • 22. Bedside determination of aminoglycoside therapy in the patient with renal insufficiency.
    Edwards FH; Davies RS
    Surg Gynecol Obstet; 1983 Jan; 156(1):67-8. PubMed ID: 6847946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside pharmacokinetics in neonates: the need to search for covariates of variability in addition to case descriptions.
    Allegaert K
    Acta Paediatr; 2009 Oct; 98(10):1546; author reply 1546-7. PubMed ID: 19659582
    [No Abstract]   [Full Text] [Related]  

  • 24. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.
    Giuliano RA; Verpooten GA; De Broe ME
    Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968
    [No Abstract]   [Full Text] [Related]  

  • 25. Number of serum drug concentration determinations influences costs of pharmacokinetic dosing programs.
    Millikan MD; Farnett LE
    Am J Hosp Pharm; 1987 Feb; 44(2):278, 282. PubMed ID: 3565381
    [No Abstract]   [Full Text] [Related]  

  • 26. [Once-daily dosage of aminoglycosides--a therapeutic simplification and an economical benefit].
    Berild D; Sjursen H; Digranes A
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3152-6. PubMed ID: 10522483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intermittent antimicrobial therapy in septicemias. Comparative study in 132 cases].
    Căruntu F; Angelescu C; Predoviciu MF; Tudose M; Petcoiu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):267-74. PubMed ID: 6138840
    [No Abstract]   [Full Text] [Related]  

  • 29. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aminoglycoside antibiotics.
    Langslet J; Habel ML
    Am J Nurs; 1981 Jun; 81(6):1144-6. PubMed ID: 6909002
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse effects of antimicrobiological agents and countermeasures--TDM and countermeasures against adverse effects].
    Saito A; Yamaji T; Saigusa M
    Nihon Rinsho; 1986 Apr; 44(4):955-8. PubMed ID: 3531586
    [No Abstract]   [Full Text] [Related]  

  • 33. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aminoglycoside-induced nephrotoxicity].
    Fabrizii V; Thalhammer F; Hörl WH
    Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous versus intermittent aminoglycoside therapy.
    Stutman HR
    J Pediatr; 1987 Mar; 110(3):496-7. PubMed ID: 3819957
    [No Abstract]   [Full Text] [Related]  

  • 36. [When to prescribe an aminoglycoside in general practice?].
    Dournon E; Frottier J
    Sem Hop; 1980 Oct 18-25; 56(39-40):1623-6. PubMed ID: 6255582
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aminoglycosides in pediatrics].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection control: the aminoglycoside antibiotics.
    Messner RL
    J Pract Nurs; 1986 Dec; 36(5):14-6. PubMed ID: 3643270
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of aminoglycoside dosing on magnesium levels in hospitalised patients.
    Alkharfy KM; Al-Rasheed M; Al-Otaibi B; Al-Mitwazy A; Al-Mutairi M
    Int J Antimicrob Agents; 2007 Aug; 30(2):189-90. PubMed ID: 17560086
    [No Abstract]   [Full Text] [Related]  

  • 40. Computer program for aminoglycoside dosing.
    Harless GR; Yu FH
    Am J Hosp Pharm; 1985 Oct; 42(10):2144. PubMed ID: 3840648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.